O. OKCU Et Al. , "Tumor-infiltrating lymphocytes (TILs)/volume and prognosis: The value of TILs for survival in HER2 and TN breast cancer patients treated with chemotherapy," ANNALS OF DIAGNOSTIC PATHOLOGY , vol.58, 2022
OKCU, O. Et Al. 2022. Tumor-infiltrating lymphocytes (TILs)/volume and prognosis: The value of TILs for survival in HER2 and TN breast cancer patients treated with chemotherapy. ANNALS OF DIAGNOSTIC PATHOLOGY , vol.58 .
OKCU, O., Ozturk, S., Ozturk, C., Sen, B., YASİN, A. İ., & BEDİR, R., (2022). Tumor-infiltrating lymphocytes (TILs)/volume and prognosis: The value of TILs for survival in HER2 and TN breast cancer patients treated with chemotherapy. ANNALS OF DIAGNOSTIC PATHOLOGY , vol.58.
OKCU, OĞUZHAN Et Al. "Tumor-infiltrating lymphocytes (TILs)/volume and prognosis: The value of TILs for survival in HER2 and TN breast cancer patients treated with chemotherapy," ANNALS OF DIAGNOSTIC PATHOLOGY , vol.58, 2022
OKCU, OĞUZHAN Et Al. "Tumor-infiltrating lymphocytes (TILs)/volume and prognosis: The value of TILs for survival in HER2 and TN breast cancer patients treated with chemotherapy." ANNALS OF DIAGNOSTIC PATHOLOGY , vol.58, 2022
OKCU, O. Et Al. (2022) . "Tumor-infiltrating lymphocytes (TILs)/volume and prognosis: The value of TILs for survival in HER2 and TN breast cancer patients treated with chemotherapy." ANNALS OF DIAGNOSTIC PATHOLOGY , vol.58.
@article{article, author={OĞUZHAN OKCU Et Al. }, title={Tumor-infiltrating lymphocytes (TILs)/volume and prognosis: The value of TILs for survival in HER2 and TN breast cancer patients treated with chemotherapy}, journal={ANNALS OF DIAGNOSTIC PATHOLOGY}, year=2022}